Show items per page
Elements: 34
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
Molecular electrostatic potentials for characterizing drug-biosystem interactions Carrupt, Pierre-Alain; el Tayar, Nabil; Karlen, A.; Testa, Bernard 1991
add to browser selection
Molecular lipophilicity potential, a tool in 3D QSAR: method and applications Gaillard, Patrick; Carrupt, Pierre-Alain; Testa, Bernard; Boudon, Alain 1994
add to browser selection
Lipophilicity in molecular modeling Testa, Bernard; Carrupt, Pierre-Alain; Gaillard, Patrick; Billois, F.; Weber, P. 1996
add to browser selection
Molecular lipophilicity potential (MLP) in drug design. Complementing theoretical tools with experimental results Carrupt, Pierre-Alain; Gaillard, Patrick; Billois, F.; Weber, P.; Testa, Bernard 1996
add to browser selection
A systems approach to molecular structure, intermolecular recognition, and emergence-dissolvence in medicinal research Testa, Bernard; Kier, Lemont B.; Carrupt, Pierre-Alain 1997
add to browser selection
The Hydrogen-Bond: computational approaches and applications to drug design Rey, S.; Carrupt, Pierre-Alain; Testa, Bernard 2002
add to browser selection
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors Hartley, Oliver; Gaertner, Hubert François; Wilken, Jill; Thompson, Darren; ... Offord, Robin Ewart 2004
add to browser selection
Engineering chemokines to develop optimized HIV inhibitors Hartley, Oliver; Offord, Robin Ewart 2005
add to browser selection
Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling Vyroubalova, Eva Cachin; Hartley, Oliver; Mermod, Nicolas; Fisch, Igor 2006
add to browser selection
Impact of species-dependent differences on screening, design, and development of MAO B inhibitors Novaroli, L.; Daina, Antoine; Favre, Elisabeth; Bravo, Juan; ... Reist, Marianne 2006
add to browser selection
Chaperoning steroid hormone action Picard, Didier 2006
add to browser selection
Structural basis of thiamine pyrophosphate analogues binding to the eukaryotic riboswitch Thore, Stéphane; Frick, Christian; Ban, Nenad 2008
add to browser selection
High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media Bard, Bruno; Martel, Sophie; Carrupt, Pierre-Alain 2008
add to browser selection
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 Gaertner, Hubert François; Lebeau, Olivier; Borlat, Irène; Cerini, Fabrice; ... Hartley, Oliver 2008
add to browser selection
Development and validation of target-based drug design tools: virtual screening of monoamine oxidase inhibitors Bravo, Juan 2009
add to browser selection
Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets Jaquet, Vincent; Scapozza, Leonardo; Clark, Robert A.; Krause, Karl-Heinz; Lambeth, J David 2009
add to browser selection
QSAR analysis and molecular modeling of ABCG2-specific inhibitors Nicolle, Edwige; Boumendjel, A.; Macalou, S.; Genoux, E.; ... Di Pietro, A. 2009
add to browser selection
Mode of action of adjuvants: implications for vaccine safety and design Mastelic-Gavillet, Beatris; Ahmed, Sohail; Egan, William M.; Del Giudice, Giuseppe; ... Lambert, Paul Henri 2010
add to browser selection
Psychopharmacological treatment in pathological gambling: a critical review Achab, Sophia; Khazaal, Yasser 2011
add to browser selection
Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview Ing Lorenzini, Kuntheavy; Daali, Youssef; Dayer, Pierre; Desmeules, Jules Alexandre 2012
<< previous | 1 | 2 |